EFFICACY AND TOLERABILITY OF NEBIVOLOL COMPARED WITH OTHER ANTIHYPERTENSIVE DRUGS: A META-ANALYSIS
Aim: Lowering BP to normal levels without quality of life deterioration is the most important means of reducing cardiovascular risk. Recent studies have challenged the position of beta-adrenoreceptor antagonists (beta-blockers) as first-line antihypertensive drugs. Nebivolol is a third-generation, h...
প্রধান লেখক: | , , |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | Russian |
প্রকাশিত: |
«FIRMA «SILICEA» LLC
2011-02-01
|
মালা: | Российский кардиологический журнал |
অনলাইন ব্যবহার করুন: | https://russjcardiol.elpub.ru/jour/article/view/1091 |